Seven Mile Advisory’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$941K Sell
3,851
-2,669
-41% -$622K 0.68% 21
2025
Q4
$1.35M Sell
6,520
-1,044
-14% -$206K 0.23% 60
2025
Q3
$1.4M Buy
7,564
+2,782
+58% +$477K 0.23% 65
2025
Q2
$730K Sell
4,782
-1,265
-21% -$194K 0.44% 34
2025
Q1
$1M Buy
6,047
+1,690
+39% +$264K 0.67% 28
2024
Q4
$630K Sell
4,357
-1,485
-25% -$230K 0.4% 43
2024
Q3
$947K Buy
5,842
+1,001
+21% +$159K 0.63% 29
2024
Q2
$708K Buy
4,841
+84
+2% +$12.5K 0.52% 34
2024
Q1
$753K Buy
4,757
+671
+16% +$107K 0.57% 32
2023
Q4
$640K Buy
4,086
+691
+20% +$106K 0.56% 36
2023
Q3
$529K Buy
3,395
+404
+14% +$66.7K 0.56% 40
2023
Q2
$495K Buy
+2,991
New +$483K 0.58% 42

Other funds holding JNJ

Seven Mile Advisory's JNJ Position: Q1 2026 in Review

Seven Mile Advisory reduced its Johnson & Johnson (JNJ) stake by 41% in Q1 2026, selling an estimated $622K and leaving 3,851 shares worth $941K. The position accounts for 0.68% of the portfolio, ranked #21.

Seven Mile Advisory first reported a position in JNJ in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.4M in Q3 2025. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Seven Mile Advisory held 3,851 shares of Johnson & Johnson worth $941K as of Q1 2026.
  • Seven Mile Advisory sold 2,669 Johnson & Johnson shares in Q1 2026, an estimated $622K.
  • Johnson & Johnson made up 0.68% of Seven Mile Advisory's portfolio in Q1 2026, its #21 holding.
  • Seven Mile Advisory first reported a position in Johnson & Johnson in Q2 2023 and has held it in 12 quarters since.
  • Seven Mile Advisory's Johnson & Johnson position peaked at $1.4M in Q3 2025.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Seven Mile Advisory's 13F filing for Q1 2026, filed 14 Apr 2026.